Abstract Dysphagia experienced as a consequence of neurodegenerative disease can have severe consequences on a patient's health and well-being. Regular assessment of swallowing function can assist to achieve adequate nutrition and hydration. Here we review subjective swallowing assessments currently available are suitable for use in people with neurodegenerative disease. Measurement properties were reviewed for each tool and coverage of the World Health Organization's International Classification of Functioning, Disability and Health (WHO ICF) was considered. Assessments were identified following a review of the published literature Instruments were reviewed on the basis of reliability and validity, as well as administrative properties, such an interpretability, acceptability, and feasibility. Tools were also evaluated according to the WHO ICF framework. In total, 19 studies were identified for fulltext review from 13,315 abstracts. Nine self-reported dysphagia assessment tools suitable for use in progressive neurological disorders were identified. The Swallowing Quality of Life Questionnaire (SWAL-QOL) yields the strongest combination of reliability (including internal consistency and test-retest reliability) and convergent validity while simultaneously covering all WHO ICF domains. Lengthy administration time was identified as a limitation of the SWAL-QOL. The review highlights a relative lack of well-validated self-report questionnaires in dysphagia for people with progressive neurological disease. Additional validation and evaluation of the clinical utility of the tools currently available is required to further promote an informed selection of available assessments.
Introduction
Dysphagia is an expected symptom of neurodegenerative disease. Common symptoms of dysphagia include coughing or choking, reduced mastication, difficulty controlling solids or liquids in the mouth, drooling, nasal regurgitation, food lodging in the pharynx, and aspiration (matter entering the lungs). In the case of neurodegenerative conditions, these symptoms may be exacerbated by co-existing changes to motor control, making it difficult to manipulate cutlery and feed independently. People with dysphagia are at risk of malnutrition, dehydration, and pneumonia secondary to aspiration [26] , which is the leading cause of death in people with multiple sclerosis (MS) [1] and Parkinson's disease (PD) [13] . Dysphagia also has associated social and psychological consequences that affect overall quality of life (QOL), including reduced mental health, self-esteem, and social isolation [9] . The prevalence of dysphagia in neurodegenerative diseases is high, with 20-80 % of people with PD [7, 28] and over 30 % of those with MS [23] experiencing swallowing impairment. Despite being highly prevalent, dysphagia is chronically under-reported in neurodegenerative populations with initial diagnosis often occurring with an episode of aspiration pneumonia [18] .
Identifying dysphagia in the early stages of a progressive neurological disorder can assist in implementing preventative measures, reduce the risk of complications, and assist in achieving optimal health and QOL outcomes [4] . There are often complex social and psychological dynamics associated with neurodegenerative conditions that must be considered in the assessment process. The World Health Organization's International Classification of Functioning, Disability, and Health (WHO ICF) [32] provides a multifaceted framework for health by considering disability at the level of body functions and structures, potential activity undertaken by the individual, and participation in everyday life [22] . The framework is important in the consideration of outcome measures to ensure a holistic approach to assessment. Traditionally, swallowing assessment consists of a clinical bedside assessment and instrumental analysis if indicated, including Videofluoroscopic Study of Swallowing (VFSS) and Fibreoptic Endoscopic Evaluation of Swallowing (FEES). The typical bedside evaluation of swallowing is clinical and methodical in nature, with emphasis on the physiological consequences of swallowing impairment. Assessment is usually performed in a medical setting, with little talking, and the patient is required to eat food that they may not consider appealing. The Speech Language Pathologist will then provide an objective assessment report. Threats [26] compares this clinical setting with a more natural and social setting, where there is often talking when eating and drinking and the food available is likely to be more appealing than that offered in the clinical setting. The experience and therefore the performance of eating and drinking are markedly different between these two settings [26] . Instrumental analysis is used to facilitate a further understanding of the physiological and mechanical aspects of swallowing in order to develop an overall impression of dysphagia severity. Although considered the gold standard of dysphagia assessment [10] , instrumental analysis is a poor measure of overall functional disability, and forming recommendations on the basis of the results of instrumental analysis alone may lead to a management approach that has little practicality to the patient [26] . A qualitative, patient-centered assessment tool allows for reliable evaluation of the psychosocial burden often associated with dysphagia, as well as overall impact on QOL [3, 29] . Self-reported assessments can be completed autonomously away from the clinical setting and results can identify patients in need of more invasive instrumental assessment [8] .
Despite their advantages, self-reported swallowing assessments are not routinely adopted into clinical practice. This may be reflective of the lack of awareness of dysphagia in people with neurodegenerative disease, or that no one tool has been identified as preferable for use in these populations. This study presents an evaluation of the psychometric and administrative properties of self-reported swallowing assessments found in the literature and suitable for use in neurodegenerative disorders. The relevance of each tool to the WHO ICF framework was also assessed.
Methods
Searches were conducted using the Medline, CINAHL, and ScienceDirect databases, for the years 1990 to October, 2013. The following keywords were used: dysphagia or deglutition disorder* or swallowing disorder* and questionnaire or assessment or survey and progressive neurological or multiple sclerosis or Parkinson's disease and quality of life. A further search was conducted via the Google search engine to ensure all assessments in the public domain were retrieved. All possible combinations of the terms subjective, self-reported, dysphagia, swallowing disorder*, deglution disorder*, questionnaire, assessment, and survey were used, and the first ten pages of search results scanned. Two authors (MK and AV) independently screened the relevant titles to exclude papers that were obviously irrelevant then evaluated the abstracts to determine eligibility for full text review. The reference lists of selected articles were also searched to identify additional papers for inclusion in this review. In the event of disagreement over inclusion of a particular paper, all listed authors formed a consensus by reassessing the inclusion criteria. The search was not restricted to English language papers.
Types of Studies
Papers were included for full text review if they contained information on the development or validation of subjective or self-reported dysphagia questionnaires or assessments. Assessment tools were included in the review if they were used in neurodegenerative disease populations.
Types of Study Participants
Participants included were of any age, sex, ethnicity, and stage of illness. Studies were only included if their participants had a genetically or clinically confirmed diagnosis of a progressive neurological disorder.
Outcome Measures
Identified tools were assessed according to reliability and validity, as well as administrative properties, such as interpretability, acceptability, and feasibility (refer to Table 1-Evaluation criteria for assessment tools). Assessment tools were also assessed in regards to their relevance to the WHO ICF.
Results
A total of 13,315 papers were identified from the database searches after duplicates were removed. Two authors (MK and AV) screened the abstracts of these papers and excluded those that were obviously irrelevant. Papers were primarily excluded for focusing on dysphagia secondary to different etiologies (for example, stroke, gastroeosophageal reflux disease, chronic obstructive pulmonary disease, cervical spine surgery, laryngectomy, or head and neck cancer). In total, 19 papers were included for full text review based on our inclusion criteria. No further papers were identified following a search of the reference lists of the papers identified for a full text analysis. A search was conducted using the Google search tool, however, no further papers were identified as appropriate for inclusion in this review (refer to Fig. 1 ). In total, nine subjective swallowing assessments evaluated in neurodegenerative populations were identified in the literature. All of the assessments had information regarding psychometric evaluation. Features of each screening tool (listed alphabetically) are described in Table 2 . Measurement and administrative characteristics of each tool (reliability, validity, and sensitivity/specificity) are summarised in Table 3. Table 4 shows each individual assessment's relevance to the WHO ICF framework. Table 5 in Appendix contains a more detailed analysis of each assessment and its individual items in compliance with the WHO ICF.
Dysphagia in Multiple Sclerosis (DYMUS)
Questionnaire [4] The Dysphagia in Multiple Sclerosis Questionnaire (DY-MUS) was designed as a screening tool for dysphagia in the early stages of the disease. The DYMUS primarily aims to identify patients in need of further assessment in order to reduce the potential health and social consequences of dysphagia in MS. The DYMUS assesses dysphagia to solids and dysphagia to liquids, with each item answered dichotomously, either positive (1) or negative (0) depending on the presence or absence of a dysphagic event [4] . The DYMUS was validated in a cohort of 1,734 patients across 13 MS specific centers, with 31 % (n = 541) recording at least one abnormal response.
The DYMUS primarily addresses the Body Functions component of the WHO ICF (see Table 4 ). Nine items on the DYMUS assess for difficulty chewing particular types of food, weight loss, globus post swallow, coughing and choking with oral intake, and requiring multiple sips or swallowing to clear a bolus. The remaining item on the DYMUS relates to activity limitation (cutting food into small pieces before swallowing).
Advantages: DYMUS
The DYMUS is currently the only validated MS-specific subjective dysphagia questionnaire [4] . At only 10 items in length, the DYMUS is brief to administer and interpret, reducing clinical burden. As the DYMUS is divided into two subscales, it can be used to assess dysphagia to solids or liquids independently, which can assist in guiding dysphagia management [12] . The reliability and homogeneity of the DYMUS (Cronbach's alpha 0.91, where [0.70 is considered good) is excellent [5] making the DYMUS a consistent tool to include in the dysphagia assessment battery.
Limitations: DYMUS
The DYMUS focuses on the physiological implications of dysphagia, with the main aim of aspiration prevention [4] . It is therefore a limited indicator of social and psychological impact of dysphagia. Given the DYMUS is validated solely in the MS population, use in other neurodegenerative conditions requires further independent validation.
Dysphapark Questionnaire (DQ) [2] The DQ was developed to assess the level of awareness of dysphagia in the PD population. The DQ contains 18 items divided into two subscales-swallowing efficiency (9 items) and swallowing safety (9 items). Each item relates to a specific swallowing-related event and is scored from 0 to 3, where 0 = never, 1 = sometimes, 2 = often, and 3 = always. To validate the DQ, the authors sent 2,000 copies to PD patients from 27 Spanish provinces. Patients were selected by movement disorder neurologists. From these 2,000 questionnaires, 470 were returned to the authorship group via post (23.5 %). Ninety percent of these participants were found to have problems of efficacy and safety of swallowing whilst 79.45 % were not aware of having dysphagia. The DQ predominantly addresses body function and structures of the WHO ICF, focusing on physiological breakdown of the swallowing process.
Advantages: Dysphapark Questionnaire
The DQ is short and does not contain subscales or visual scales that require the calculation of a raw score, adding to its ease of use.
Limitations: Dysphapark Questionnaire
The survey was sent via mail, with little information pertaining to how patients were orientated to the survey prior to receiving it. There was a low response rate (470/2,000; 23.5 %). It is possible that respondents were not representative of the PD population. The DQ requires further psychometric evaluation in a broader population group in terms of age and severity of disease. The participant group consisted predominantly of patients with less severe symptoms as measured by Hoehn and Yahr scaling [14] . Most of the participant group (83.7 %) were in stages I and II of the disease, with only 5.6 % in stage IV-V (more severe). Comparison between questionnaire results and instrumental or electrophysiological measures of swallow would further promote the validity of the tool. Currently the DQ is only available in Spanish and requires validation in other languages.
Eating Assessment Tool (Eat-10) [3] The EAT-10 was developed by a team of dysphagia experts from multiple professions, including gastroenterology, otolaryngology, speech language pathology, and nutrition. Its creation was motivated by a survey of 200 Speech Language Pathologists (SLP) in California, USA. The results of this survey indicated that self-rated swallowing questionnaires were not routinely used in clinical practice. The authors cited length of administration and scoring time as a possible explanation, as well as pre-existing questionnaires only focusing on isolated groups of dysphagia patients and therefore not appropriate for wider use. Each item on the EAT-10 is scored by the patient on a scale from 0 to 4, where 0 indicates no problem, and 4 indicates severe problem. A score C3 on any individual item is considered abnormal and indicative of dysphagia [3] . The EAT-10 was validated in a cohort of 235 individuals, 21 % (n = 50) of whom presented with oropharyngeal dysphagia of neurological origin, including stroke, PD, amyotrophic lateral sclerosis, or pseudobulbar palsy.
The EAT-10 predominantly addresses body function and structures of the WHO ICF, focusing on physiological breakdown of the swallowing process. Two items relate to Internal consistency: Cronbach's alpha coefficient (a) 0.96
Test-retest reliability:
Pearson product coefficient ranged from 0.72 to 0.91 [3] Validity was determined by administering the EAT-10 before and after dysphagia treatment, and by evaluating the assessment results of controls versus people with known dysphagia. The mean EAT-10 scores of dysphagic patients improved from 19.87 ± 10.5 to 5.2 ± 7.4 after treatment (P \ 0.001) [3] Not documented Internal consistency: Cronbach's alpha coefficient (a) 0.8 [8] 92 % of patients with SDQ score of 11 (optimal score) had swallowing disturbances confirmed by physical examination; 38 % of patients with total SDQ score 11 had swallowing disturbances on physical examination [18] When SDQ responses regarding the oral phase of swallowing were correlated with findings from an oro-motor examination, sensitivity was 85.7 %, and specificity was 87.6 %. When responses focusing on the phase of swallow were compared with FEES examination, sensitivity was 67.3 % and specificity was 76.7 %. When the total SDQ score was correlated with the total oral motor and the FEES scores, overall sensitivity was 79.7 % and specificity was 73 % [8] Swallowing Quality of Life (SWAL-QOL) questionnaire Test-re-test: D scores were calculated for each individual item on the SSQ. D values for normalized scores ranged from -2 to 17 %. The confidence intervals for all D values neared 0, indicating that no retest score differed significantly from its baseline score [29] Face validity: 25/32 (78 %) authorities in the field of dysphagia responded to face-validity survey. 14/19 (74 %) questions were rated as moderately or highly relevant by more than 80 % of respondents
Construct validity:
The total inventory score demonstrated high linear correlation with global assessment score, where r = 0.69, P \ 0.0001 [29] Not documented Criterion validity: Assessed using VFSS. A subgroup of patients (n = 60) underwent VFSS and were divided into severity groups based on results-normal (n = 19), mild (n = 29), and moderate/severe (n = 12). A significant difference was found between these severity groups (as measured by ANOVA methods): Total DHI-P = 0.003
Physical scale-P = 0.049
Functional scale-P = 0.001
Emotional scale-P = 0.009
Construct validity: Pearson correlations were conducted between scales
Emotional and Functional Scalesr = 0.77 Physical and Functional Scalesr = 0.72 Physical and Emotional Scalesr = 0.66 Wilcoxon two-sample tests were used to compare the dysphagia and control groups in the original validation study. The control group demonstrated lower scores for all scales compared to the dysphagia group (P \ 0.001 for the total score, and each individual subscale). Close to all participants in the control group marked zero or ''never,'' indicating perceived normal swallowing [24] Not documented possible impact on activity; ''The pleasure of eating is affected by my swallowing,'' and ''Swallowing is stressful.'' Only one item assesses the impact on participation (''my swallowing problem interferes with my ability to go out for meals'') (see Table 4 ).
Advantages: Eat-10
The EAT-10 is quick to administer at less than 2 min [3] . In a comparison of swallowing-specific questionnaires, the EAT-10 was found to be more easily read and understood than others [33] , supporting its use in progressive neurological populations with associated cognitive decline. The EAT-10 does not contain subscales or visual scales that require the calculation of a raw score, further adding to its ease of use. The probe statements are designed to be symptom-specific to the oral and pharyngeal phases of swallowing. The psychometric properties of the EAT-10 indicate good test-retest reproducibility (refer to Table 2 ), making its use advantageous in everyday clinical practice [3] .
Limitations: EAT-10
The EAT-10 has not been evaluated in longitudinal studies and therefore its effectiveness in the measurement of dysphagia progression over time is unknown. The EAT-10 focuses on the physiological implications of dysphagia, and does not address possible social, emotional, and functional impacts. The authors argue this omission is offset by the test's simplicity, ease of use, ease of scoring, and application to dysphagic patients of varying causes. The authors of the EAT-10 acknowledge the need for further validation across age, race, and socioeconomic groups [3] .
Radboud Oral Motor Inventory for Parkinson's Disease (ROMP) [15] The Radboud Oral Motor Inventory for Parkinson's disease (ROMP) consists of three subscales: speech, swallowing, and saliva control. For the purpose of this paper, only the dysphagia subscale is reviewed. The ROMP dysphagia component was developed after a review of three already existing assessments-the Dutch version of the Swallowing Quality of Life (SWAL-QOL) questionnaire [6] , the Performance Status Scale for Head and Neck Cancer Patients [17] , and the Swallowing Disturbance Questionnaire (SDQ) [18] . Each item is scored from 1 to 5 (where 1 = normal and 5 = most severe). The items on the ROMP swallowing subscale probe for choking episodes during oral intake, limitations relating to drinking and eating, difficulty swallowing pills, limitations regarding dining with others, concerns regarding swallowing difficulties, and the degree of bother the patient experiences secondary to their swallowing difficulties.
The three components of the ROMP were designed to assess speech, swallowing, and saliva control issues specific to PD according to the components of the WHO ICF (see Table 4 ) [15] . The swallowing component alone covers items mainly referring to Body Functions and Structures. One item, ''Does your swallowing difficulty limit your dining with others?'' addresses possible limitation on participation.
Advantages: ROMP
The ROMP is short in order to ease administrative and patient burden [15] . The psychometric properties of the ROMP are strong (refer to Table 2), with high internal consistency. The authors controlled for any associated cognitive impairment expected in the PD population by repeating every item in the response possibility [15] .
Limitations: ROMP
The ROMP was validated on community-dwelling patients with mild to moderate symptoms, and not severe or hospitalised patients. The authors raise issues with subjectivity, in that people with PD tend to rate symptoms, such as speech intelligibility, as being less severe than their caregivers. Low patient-proxy agreement may justify the creation of a caregiver-rated version of the ROMP [15] .
Swallowing Disturbance Questionnaire (SDQ) [8] The SDQ was designed for use in the PD population, and can be completed periodically throughout the course of the disease to detect and monitor dysphagia. During development, results of the SDQ were compared with results of a clinical oral-motor examination and FEES [8] .
The SDQ contains 15 items covering dysphagia symptoms that appear in the oral and pharyngeal phases of swallowing. Questions 1-14 are marked on a scale ranging from 0 to 3 where 0 = never, 1 = seldom (once a month or less), 2 = frequently (1-7 times a week), 3 = very frequently ([7 times a week). Question 15 is answered with a ''yes'' or ''no,'' scoring 0.5 or 2.5, respectively. A score of more than 12.3 (determined in a population of varying etiologies) indicates the likely presence of dysphagia [8] .
The SDQ solely addresses the body functions domain of the WHO ICF (see Table 4 ).
Advantages: SDQ
Originally designed specifically for PD, the SDQ has been used in dysphagic populations of different etiologies, including stroke, other neurodegenerative disease, gastrointestinal disease, and following head and neck surgery [8] .
Responses to the SDQ items have been found to correlate with results of structural and instrumental analysis (for example, oral motor examination and FEES) (79.7 % sensitivity, 73 % specificity) [8] . The SDQ is short and although administration time is not documented in the initial development paper [18] , it is estimated to take 10 min or less to complete [10] .
Limitations: SDQ
Individuals who participated in the SDQ validation study were referred by a SLP, and thus were likely to be presenting with a speech, voice, or swallowing impairment prior to assessment. Therefore, the SDQ scores were likely higher in the participant group than that of the general PD population [8] . All PD patients in the original SDQ development study were assessed in their on state (approximately one to 2 h post-anti-Parkinson's medication). This may have affected the results of the SDQ, as patients might experience swallowing disturbances only in their off state and, if so, an examination performed during their on state may fail to detect any impairment. In the original validation study, results of the SDQ were compared with a non-standardized oral motor examination, conducted and subjectively rated by a SLP. Inter-rater reliability between the SLP rating the oral motor examination was not determined.
Sydney Swallow Questionnaire (SSQ) [29] The SSQ was designed to measure the symptomatic severity of oropharyngeal dysphagia of various etiologies [29] . The SSQ covers three swallowing variables: (1) anatomical region (oral cavity, glottis, and pharynx); (2) type of dysfunction; and (3) swallowed bolus consistency. Within each anatomical region, the potential functional disturbances are considered. Seventeen of the nineteenth questions are answered by marking a 10 mm horizontal visual analogue scale X 0 at the point which the patient feels best represents the severity of the particular dysfunction. The distance to the centre of the marked ''X'' from the lefthand side of the line is measured to the nearest millimeter and converted to a score out of 100. The maximum possible score is therefore 1,700, with a higher score indicating more severe impact on swallowing. Questions 12 and 13 yield single integer scores from 0 to 5 and 0 to 3, respectively, based on eating times for an ''average meal'' and ''a scoop of ice cream.'' The SSQ was validated in a group of individuals with dysphagia of various etiologies (n = 48). Twelve (25 %) of this group presented with PD, 4 (8.3 %) presented with a movement disorders (e.g., dystonia), and 6 (12.5 %) presented with amyotrophic lateral sclerosis. The results from this group were compared to a global dysphagia score determined by instrumental examination and other clinical indicators. Face validity of the SSQ was determined by a poll of 25 experts in the field of dysphagia. Sixteen of the 19 items were deemed to be moderately to highly relevant by more than 80 % of respondents, and three questions were deemed to have little relevance by 30 % of respondents. These three questions related to time taken to eat a scoop of ice cream (item 13), reports of drooling (item 17), and perceived severity of the persons swallowing problem on the day of assessment (item 18). Two of these questions were subsequently removed (items Table 5 in Appendix for a detailed outline of each assessment's individual items in relation to the WHO ICF framework 13 and 17), with item 18 remaining as it was deemed significant by factor analysis [29] . The final SSQ therefore consists of 17 items. The SSQ focuses on the WHO ICF domain of body function and structure, with 9 of the 17 items assessing issues related to the different phases of swallowing (see Table 4 ). One item on the SSQ addresses the overall health condition, by a subjective rating of their overall swallowing impairment. The SSQ also addresses participation, asking the patient to rate the overall interference of dysphagia on QOL. Five items on the SSQ are related to possible environmental factors that may affect swallowing, by probing for difficulty swallowing certain textures and consistencies of solids and fluids. One item on the SSQ relates to the time required to eat an average meal. Given that time allowed for a meal is often dictated by external factors, such as the clinical setting or availability of feeding assistance, this item could be considered an environmental consideration.
Advantages: SSQ
The SSQ is not disease-specific, making it an appropriate tool for use in a variety of dysphagia groups. The SSQ demonstrated a high level of reliability in detecting dysphagia without direct clinical evaluation when compared to the global dysphagia score (refer to Table 2 ).
Limitations: SSQ
The SSQ is scored on a visual analog scale, which some argue ads burden to the scorer when compared to a dichotomous, or Likert scale [3] . This may make the SSQ less desirable to some clinicians.
Swallowing Quality of Life (SWAL-QOL) Questionnaire [19] One of two patient-centered outcome tools (the other being the SWAL-CARE; a 15-item tool that assesses quality of care and patient satisfaction), the SWAL-QOL was designed to assess the physical, social, psychological, and cultural experiences associated with eating [21] . The SWAL-QOL contains 44 items covering 10 quality of life domains pertaining to dysphagia. Each item is answered on a 5-point Likert scale, with different instructions to the patient for different areas of assessment. Each item is equally weighted and calculated into an overall score, with a lower score indicating a worse QOL. The SWAL-QOL was validated in a cohort of 386 participants, with 49 (12.7 %) having a progressive neurological disease [20] .
The SWAL-QOL addresses multiple WHO ICF domains (see Table 4 ). Issues relating to the overall health condition are addressed with broad questions, such as ''Feel weak?,'' ''Feel tired?,'' ''Feel exhausted?,'' and by asking the patient to mark their overall health as poor, fair, good, very good, or excellent. The SWAL-QOL probes for issues relating to Body Function and Structure across multiple stages of swallowing (oral, pharyngeal, esophageal) by probing for coughing with oral intake, food sticking in mouth and throat, difficulty chewing, and issues with speech intelligibility and saliva management. Psychological consequences of dysphagia, such as fear or anxiety related to eating and drinking, are also considered in the SWAL-QOL items, and can be classified as an impairment, and therefore also fall under the category of Body Function. The SWAL-QOL also probes for changes to activities and participation behaviours, including not going out to eat, restrictions on social life, reduced desire to eat, and extended mealtimes. There are no direct questions relating to environmental factors in the SWAL-QOL, however, personal factors are addressed by questions relating to demographic information including ethnicity/race, years of schooling, and marital status.
Advantages: SWAL-QOL
The SWAL-QOL can be self-administered, administered by an interviewer, or can be completed by a proxy, such as a friend or family member [19] . Statistically, the SWAL-QOL has adequate content validity, with all items demonstrating acceptable internal consistency (see Table 2 ). Although originally designed for an English-speaking population, the SWAL-QOL has since been validated in Dutch [6] and French [16] populations. The SWAL-QOL provides a holistic approach to dysphagia assessment, as evidenced by the inclusion of items that cover all WHO ICF domains.
Limitations: SWAL-QOL
The SWAL-QOL takes longer to complete compared to other swallowing questionnaires reviewed in this paper. The longer administration time results in increased clinical burden and may limit the widespread use of the SWAL-QOL in clinical practice [3] . The complexity of the wording in the SWAL-QOL also restricts its use in populations with lower literacy levels [24] . The wording of the SWAL-QOL is argued to be more complex compared to similar assessments [33] , and the patient may require increased cueing to complete the tool, further contributing to clinical burden [24] .
The Deglutition Handicap Index (DegHI) [31] The Deglutition Handicap Index (DegHI) was created by a group based in France following evaluation of existing swallowing questionnaires. The authors found that preexisting questionnaires were designed for a specific etiology or patient group (level of illness severity), and had not been translated into French. Formatted to mirror the ''Voice Handicap Index,'' the DegHI consists of 30 swallowing related aspects in daily life. It is subdivided in three domains of 10 items: physical (symptoms), functional (nutritional and respiratory consequences), and emotional (psychosocial consequences). Each item is answered on a 5-point rating scale (where 0 = never, 1 = almost never, 2 = sometimes, 3 = almost always, 4 = always). The DegHI was validated in a group of 149 individuals, consisting of a 53-strong control group (including SLP students and professors, patients' family members, and employees of a functional education center), and 96 patients with varying pathologies, of whom 25 had a progressive neurological illness. The authors hypothesized that for the Physical domain, reported symptoms would correlate with radiological examination of swallowing. For the Functional domain, in the absence of a test measuring respiratory impact, the authors correlated the responses with nutritional status using the ''Nutritional Risk Screening,'' body mass index (BMI), and a measurement of meal duration. For the validity of the Emotional domain (psychological impact), scores were correlated with COOP/ WONCA charts, which evaluate the QOL of patients with chronic illnesses [31] .
The DegHi addresses multiple WHO ICF domains (see Table 4 ), including body function and structure, activity, and participation.
Advantages: DegHI
The DegHI is not disease-specific, making it an appropriate tool for use in a variety of dysphagia groups. The probe statements are short in length, making the DegHI appropriate for patients with early cognitive decline.
Limitations: DegHI
The DegHI has not been evaluated in longitudinal studies and therefore its effectiveness in the measurement of dysphagia progression over time is unknown.
The Dysphagia Handicap Index (DHI) [24] The Dysphagia Handicap Index (DHI) was developed to measure the emotional, functional, and physical impact of dysphagia on a person's life. The items in DHI are based on 60 dysphagia-related statements from patients collected by the study authors. These 60 statements were reduced to create a 25-item test consisting of a 9-item physical scale, a 7-item emotional scale, and a 9-item functional scale. Each probe statement is scored by the patient according to personal applicability, including ''never,'' ''sometimes,'' and ''always.'' All scores are added to provide a total DHI score. Additionally, patients are asked to indicate their overall swallowing severity at the completion of the assessment. This interval scale ranges from 1 to 7, where 1 = ''normal,'' and 7 = ''severe problem'') [24] .
The final version of the DHI was validated in a group of 63 individuals with dysphagia (40 females, mean age = 60.3 years, and 23 males, mean age = 65.5 years). The subjects were divided into groups according to their medical diagnosis. Twenty-six (41.3 %) presented with neurological impairment (including PD and ALS). The whole sample was compared with 74 healthy controls (40 females, mean age 55.8; 34 males, mean age 53.5) randomly selected from the community. The control group consisted of adults without any known dysphagia, or history of medical conditions associated with dysphagia [24] .
The three subscales of the DHI are designed to cover multiple domains of the WHO ICF (see Table 4 ). The physical subscale consists of 10 statements relating to body function and structures. Seven items in the DHI relate to activity related to eating and drinking. Questions relating to participation probed for emotions associated with eating and drinking, including embarrassment, depression, enjoyment, nervousness, anger, feelings of handicap, and fear.
Advantages: DHI
The DHI is not disease-specific, and can therefore be used in dysphagic populations of various etiologies [24] . The language used in the probe statements is easily understood, making the DHI appropriate for patients with lower literacy levels.
Limitations: DHI
In the original validation study, most of the participants reported mild to moderate dysphagia, with only a few reporting severe symptoms. Therefore, the relationship between the variability of response to dysphagia therapy is unknown. Further comparisons between the results of the DHI and instrumental analysis, such as VFSS, would provide a quantitative analysis. The authors also acknowledge that limiting patient responses to three choices may have also affected DHI sensitivity, due to reduced variability in patient responses [24] .
Discussion
Here we present a review of self-reported swallowing assessments used in progressive neurological disorders. The clinical utility of each tool was determined by comparing the psychometric properties (e.g., reliability, validity) of each tool as well as the degree of coverage of the domains of the WHO ICF framework. Our search identified nine self-report swallowing assessment tools designed for use in our target population (neurodegenerative diseases). Of those nine assessments, the SWAL-QOL yielded the strongest combination of reliability (including internal consistency and test-retest reliability), validity, and clinical application (including adherence to the WHO-ICF framework). A recent review examining the psychometric properties of four QOL questionnaires (including the SWAL-QOL, DegHI, and DHI) relating to dysphagia unspecific to neurodegenerative populations found similar results [27] . Lengthy administration time was identified as a weakness of the SWAL-QOL, as well as published psychometric data on only a relatively small population of people with neurodegenerative disease (n = 49, or 12.7 % of the participant group of 386).
Psychometric evaluation methodology varied amongst the assessment tools we identified. Reliability was determined using Cronbach's alpha coefficient (a) for all but two assessments: the DQ (where internal consistency was determined using the Person Separation Index-PSI) and the SSQ (where test re-test reliability was determined using D scores). Of the tools which used a to determine internal consistency, all but the SWAL-QOL provided a total a value. For the SWAL-QOL, a was determined for each separate assessment domain. Five tools achieved excellent internal consistency (where a C 0.9). The EAT-10 yielded the highest total internal consistency (a 0.96), followed by the ''Mental Health'' and ''Social Functioning'' domains of the SWAL-QOL (a 0.94. The remaining subscales ranged from a 0.91 for ''Communication'' to 0.79 for ''Fear''), the DHI (a 0.94), the DYMUS (total a 0.914), and the DegHI (a 0.90). Whilst the ROMP scored a total a value of 0.95, the swallow subscale only achieved a ''good'' rating of 0.87. Of the 10 SWAL-QOL domains, four achieved a values greater than 0.90 (''Mental Health''-a 0.94, ''Social Functioning''-a 0.94, ''Communication''-a 0.91, and ''Fatigue''-a 0.90). Test-retest reliability was calculated for six of the assessments we evaluated. The Intraclass correlation coefficient (IC) was calculated in four of these tools and ranged from 0.91 (DegHI, and the ''Eating Desire'' subtest on the SWAL-QOL) to 0.83 (DHI) (ROMP-0.86). Person's correlation was highest in the ''Communication'' subtest of the SWAL-QOL (0.91) and the EAT-10 (0.91), indicating a high degree of test-retest correlation. Test-retest reliability for the SSQ was determined using D values which determines no retest score differed from baseline score in repeated assessments [29] .
Like reliability, the methodology for determining validity also varied amongst the tools we identified. Of the tools which achieved excellent internal consistency, the DHI showed the most significant construct validity calculated between the subscales, where r = 0.77 when calculated between the ''Emotional'' and ''Functional'' scales. The SWAL-QOL was validated against a separate measure-the Medical Health Outcomes Survey (MOS) [25] . Pearson's r value was positive across all subscales of the MOS (Health perceptionsr = 0.11-0.50, social function-r = 0.24-0.49, lonelinessr = 0.29-0.56, mental health-r = 0.20-0.52), indicating strong convergent validity.
Beyond psychometric qualities, assessments were evaluated in relation to clinical burden and application of the WHO-ICF. Only one tool (the SWAL-QOL) addressed all WHO ICF domains, following by the SSQ which covered all domains except ''Activity.'' Although psychometrically strong, the EAT-1O and the DHI only addressed three ICF domains (''Body Function and Structures,'' ''Activity,'' and ''Participation'') (refer to Table 5 in Appendix). Despite its advantages, the SWAL-QOL remains limited by lengthy administration time (e.g., average 15 min). This is particularly pertinent in the neurodegenerative population, where fatigue and cognitive decline may be an issue, impacting on a person's ability to attend to and complete a lengthy assessment. Administration times of the DYMUS, DQ, ROMP, DegHI, and DHI were not discussed in the corresponding literature (refer to Table 1 ). For the remaining four tools, administration times varied from less than 2 min (EAT-10), to 15 min (SWAL-QOL). Evaluation of the psychometric properties of any assessment can be influenced by the demographic features of the tested population, such as cognitive function, level of education, ethnicity, gender, and age. Acknowledgement and control for possible cognitive impairment is particularly pertinent to the neurodegenerative population, where cognitive decline is expected in some cases. In its development, the SWAL-QOL was controlled for differences in age, sex, race, and education between the dysphagic and control groups [20] . The ROMP appeared to be the only tool that specifically controlled for cognitive impairment, by designing the probe statements so that every item was repeated in the response possibility. The EAT-10 was designed specifically to be easily understood with high ''readability'' [3] , arguably controlling for possible cognitive impairment. The length and administration time of the SWAL-QOL could make it difficult for people with cognitive impairment to complete, where attention and comprehension may be an issue. There is an argument that as cognitive function deteriorates the method of dysphagia assessment should alter to accommodate the patient's needs. Therefore, reverting to another tool which is shorter with higher readability, such as the EAT-10, could be appropriate as the disease progresses and cognitive function declines. Another option may be relying on proxy or carer reports, as opposed to self-report. However, this may be problematic with some assessments, such as the ROMP which showed low patient-proxy agreement [15] .
Subjective reporting of dysphagia is an important but often neglected component of any clinical swallowing assessment. This study identified and reviewed self-reported swallowing assessments suitable for use in neurodegenerative diseases. We evaluated and compared each tool according to its psychometric properties, clinical utility, and application to the WHO ICF. All nine tools reviewed have been used in, or were primarily developed for neurodegenerative populations. All tools have published data on psychometric analysis, however, for most tools this information was limited, highlighting the need for further research in this field. Of the nine tools identified, the SWAL-QOL presented with the strongest combination of psychometric properties (including reliability and validity) and adherence to the WHO ICF framework.
Conclusion
Routine screening for dysphagia and assessment of subjective swallowing difficulties in neurodegenerative populations requires the use of a reliable and well-validated assessment tool. Data from our review suggest a preference for the SWAL-QOL over other tools, based on psychometric evaluation and clinical utility, including adherence to the WHO ICF framework. Supporting literature has also identified the SWAL-QOL as an appropriate tool to subjectively assess swallowing function [27] . Other standout tools identified in this review for potential use in people with neurodegenerative disease include the DHI and the EAT-10. In particular, the EAT-10 demonstrated excellent internal consistency, high readability, and is short in length, making it an appropriate alternative for patients with cognitive impairment. A potential limitation of the EAT-10 was the limited coverage of WHO ICF domains. To promote an informed selection of assessment tools, further validation and evaluation of the availability and properties of the tools currently available is required. It is difficult to find foods that I both like and can eat (ED) Do you now take any food or liquid through a feeding tube? (ED)
Please circle the letter of the one description below that best described the consistency or texture of the food you have been eating most often in the last week? (normal diet, soft foods, blended foods, most nutrition through tube feeding, all nourishment through a tube) (ED) 
